Analyst Price Target is $6.00
▲ +1,611.35% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Acasti Pharma in the last 3 months. The average price target is $6.00, with a high forecast of $6.00 and a low forecast of $6.00. The average price target represents a 1,611.35% upside from the last price of $0.35.
Current Consensus is
The current consensus among 1 contributing investment analysts is to buy stock in Acasti Pharma. This rating has held steady since August 2021, when it changed from a Hold consensus rating.